Resources from the same session
347MO - The safety and efficacy of ivonescimab in combination with chemotherapy as first-line (1L) treatment for triple-negative breast cancer (TNBC)
Presenter: Xiaojia Wang
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
348MO - A phase Ib/II study to assess the safety and efficacy of PM8002/BNT327 in combination with nab-paclitaxel for first-line treatment of locally advanced or metastatic triple-negative breast cancer
Presenter: Yanchun Meng
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
349MO - Results from a phase Ia/Ib Study of ESG401, a novel Trop2 antibody-drug conjugate, in patients with different subtypes of metastatic breast cancer
Presenter: Fei Ma
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
LBA23 - ABIGAIL: Randomized phase II study of abemaciclib plus endocrine therapy (ET) with or without a short course of induction paclitaxel in patients (pts) with previously untreated HR-positive/HER2-negative advanced breast cancer (HR+/HER2- ABC) with aggressive disease criteria
Presenter: Juan De la Haba Rodriguez
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
320MO - Tibremciclib (BPI-16350) plus fulvestrant in patients with HR+/HER2- advanced breast cancer after progressing on endocrine therapy: A randomized, multicenter, double-blind, phase III study
Presenter: Shusen Wang
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
350MO - Omission of chemotherapy and addition of the CDK4/6 inhibitor ribociclib in HER2-positive and hormone-receptor positive metastatic breast cancer – Second interim efficacy analysis of the randomized phase III DETECT V trial
Presenter: Wolfgang Janni
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA23, 320MO and 350MO
Presenter: Sandra Ximena Franco Millan
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Slides
Webcast